Job ID:
Job date: 2014-12-16
End Date:
Company : Fred Hutchinson Cancer Research Center Country : Role : Postdoc
Job date: 2014-12-16
End Date:
Company : Fred Hutchinson Cancer Research Center Country : Role : Postdoc
Job Description:
Fred Hutchinson Cancer Research Center, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation, the Center’s five scientific divisions collaborate to form a unique environment for conducting basic and applied science. The Hutchinson Center, in collaboration with its clinical and research partners, the University of Washington and Seattle Children’s, is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. Join us and make a difference!
Responsibilities
We are seeking a highly motivated postdoctoral level scientist to lead a project in cancer drug target discovery based in the laboratories of Drs. Christopher Kemp and Carla Grandori.
The Kemp/Grandori laboratories are one of eleven centers in the U.S. to join the NCI funded Cancer Target Discovery and Development Network, which aims to bridge the gap between the comprehensive molecular characterizations of human cancers and the ability to apply the information to improve patient outcomes. More information can be found at http://ocg.cancer.gov/programs/ctd2/centers.
The applicant will apply state of the art functional genetics and high throughput screening approaches to identify genes required for cancer cell survival and sensitizers to current cancer chemotherapeutic drugs. Through bioinformatic curation and functional assays, including mouse models, the applicant will prioritize and validate these as viable drug targets. The ideal applicant will have a broad background in cancer biology and genetics, with expertise in cell culture, molecular biology, genetic analysis, and animal models. This is an outstanding opportunity to perform groundbreaking cancer research with direct clinical applications. For further details see: Toyoshima et al. “Functional genomics identifies therapeutic targets for MYC-driven cancer” Proc Natl Acad Sci USA, 2012 (PMID 22623531) and Kemp and Grandori, “Functional genomics to identify unforeseen cancer drug targets”. Future Oncol. 9: 473-476, 2013.
Qualifications
A Ph.D. in the field of molecular or cellular biology, genetics or related discipline and a demonstrated track record of successful research and publication are required.
Salary is based on the NIH scale and the funding for this position is for three to four years, depending on productivity. Please note that at least two letters of recommendation will be requested as part of the screening process. Please include a cover letter detailing your interest and suitability for this position with your application.
We are a VEVRAA Federal Contractor.
Additional Info:
[Click Here to Access the Original Job Post]
Fred Hutchinson Cancer Research Center, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation, the Center’s five scientific divisions collaborate to form a unique environment for conducting basic and applied science. The Hutchinson Center, in collaboration with its clinical and research partners, the University of Washington and Seattle Children’s, is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. Join us and make a difference!
Responsibilities
We are seeking a highly motivated postdoctoral level scientist to lead a project in cancer drug target discovery based in the laboratories of Drs. Christopher Kemp and Carla Grandori.
The Kemp/Grandori laboratories are one of eleven centers in the U.S. to join the NCI funded Cancer Target Discovery and Development Network, which aims to bridge the gap between the comprehensive molecular characterizations of human cancers and the ability to apply the information to improve patient outcomes. More information can be found at http://ocg.cancer.gov/programs/ctd2/centers.
The applicant will apply state of the art functional genetics and high throughput screening approaches to identify genes required for cancer cell survival and sensitizers to current cancer chemotherapeutic drugs. Through bioinformatic curation and functional assays, including mouse models, the applicant will prioritize and validate these as viable drug targets. The ideal applicant will have a broad background in cancer biology and genetics, with expertise in cell culture, molecular biology, genetic analysis, and animal models. This is an outstanding opportunity to perform groundbreaking cancer research with direct clinical applications. For further details see: Toyoshima et al. “Functional genomics identifies therapeutic targets for MYC-driven cancer” Proc Natl Acad Sci USA, 2012 (PMID 22623531) and Kemp and Grandori, “Functional genomics to identify unforeseen cancer drug targets”. Future Oncol. 9: 473-476, 2013.
Qualifications
A Ph.D. in the field of molecular or cellular biology, genetics or related discipline and a demonstrated track record of successful research and publication are required.
Salary is based on the NIH scale and the funding for this position is for three to four years, depending on productivity. Please note that at least two letters of recommendation will be requested as part of the screening process. Please include a cover letter detailing your interest and suitability for this position with your application.
We are a VEVRAA Federal Contractor.
Requeriments :
Skills :
Areas :
Additional Info:
[Click Here to Access the Original Job Post]